TC
MNTA

TFS Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

TFS Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-52,290
Closed -$884K – 491
2017
Q2 		$884K Sell
52,290
-35,087
-40% -$534K 0.35% 77
2017
Q1 		$1.17M Buy
+87,377
New +$1.37M 0.38% 54
2016
Q4 		– Sell
-23,178
Closed -$271K – 959
2016
Q3 		$271K Sell
23,178
-152,499
-87% -$1.79M 0.06% 445
2016
Q2 		$1.9M Buy
175,677
+79,291
+82% +$818K 0.35% 25
2016
Q1 		$891K Sell
96,386
-81,775
-46% -$880K 0.13% 286
2015
Q4 		$2.64M Buy
178,161
+151,302
+563% +$2.53M 0.28% 106
2015
Q3 		$441K Sell
26,859
-9,884
-27% -$202K 0.04% 555
2015
Q2 		$838K Buy
36,743
+15,859
+76% +$316K 0.08% 382
2015
Q1 		$317K Sell
20,884
-1,393
-6% -$18.1K 0.03% 660
2014
Q4 		$268K Sell
22,277
-4,287
-16% -$49K 0.03% 756
2014
Q3 		$301K Sell
26,564
-19,586
-42% -$223K 0.03% 744
2014
Q2 		$557K Sell
46,150
-5,683
-11% -$67.1K 0.04% 606
2014
Q1 		$604K Sell
51,833
-17,922
-26% -$303K 0.04% 660
2013
Q4 		$1.23M Buy
69,755
+18,029
+35% +$303K 0.06% 476
2013
Q3 		$744K Buy
51,726
+23,380
+82% +$358K 0.03% 694
2013
Q2 		$427K Buy
+28,346
New +$374K 0.02% 969

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

TFS Capital's MNTA Position: Q3 2017 in Review

TFS Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2017, closing a stake of 52,290 shares — an estimated $884K sold.

TFS Capital first reported a position in MNTA in Q2 2013 and held it in 16 quarters. The position peaked at $2.64M in Q4 2015. 158 funds tracked by Wall St. Rank hold MNTA as of Q3 2017.

  • TFS Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 52,290 Momenta Pharmaceuticals, Inc. shares in Q3 2017, an estimated $884K.
  • TFS Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
  • TFS Capital's Momenta Pharmaceuticals, Inc. position peaked at $2.64M in Q4 2015.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.